Technical Analysis for GDR - Genedrive Plc

Grade Last Price % Change Price Change
grade A 27.0 14.89% 3.50
GDR closed down 16.07 percent on Monday, April 6, 2020, on 2.03 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Very Strong Up Up Up
Historical GDR trend table...

Date Alert Name Type % Chg
Calm After Storm Range Contraction 14.89%
NR7 Range Contraction 14.89%
Wide Bands Range Expansion 14.89%
Multiple of Ten Bearish Other -3.57%
Wide Bands Range Expansion -3.57%
Volume Surge Other -15.63%
Calm After Storm Range Contraction -15.63%
Parabolic Rise Strength -15.63%
Upper Bollinger Band Walk Strength -15.63%
Wide Bands Range Expansion -15.63%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


Genedrive Plc, formerly Epistem Holdings Plc, is a holding company engaged in molecular diagnostics business. The Company operates through segments, including Preclinical Research Services, Pharmacogenomics Services and Diagnostics. Its geographical segments include the United Kingdom, Europe, the United States of America and Asia. Its Preclinical Research Services segment provides pre-clinical testing services. Its Pharmacogenomic Services segment specializes in molecular measures of biological effect. Its Diagnostics segment is commercializing the Genedrive molecular testing platform. Its Preclinical Research Services activities relate to the testing of drugs for drug development companies. The Preclinical Research Services division has developed a range of models across therapeutic pathways, including oncology, gastrointestinal disease, skin care and wound healing. The Pharmacogenomics Service offers multi system transcriptional profiling and laser capture microscopy.
Biotechnology Health Asia Drug Development Life Sciences Health Sciences Laser Pharmacology Medical Genetics Pre Clinical Development

Is GDR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 40.0
52 Week Low 6.25
Average Volume 709,745
200-Day Moving Average 19.40
50-Day Moving Average 14.34
20-Day Moving Average 17.60
10-Day Moving Average 26.62
Average True Range 5.37
ADX 56.17
+DI 35.47
-DI 14.65
Chandelier Exit (Long, 3 ATRs ) 23.89
Chandelier Exit (Short, 3 ATRs ) 24.01
Upper Bollinger Band 38.03
Lower Bollinger Band -2.84
Percent B (%b) 0.64
BandWidth 232.22
MACD Line 4.76
MACD Signal Line 3.56
MACD Histogram 1.2014
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 31.94
Resistance 3 (R3) 32.74 30.73 30.53
Resistance 2 (R2) 30.73 28.58 30.33 30.06
Resistance 1 (R1) 27.12 27.26 26.11 26.31 29.59
Pivot Point 25.11 25.11 24.61 24.71 25.11
Support 1 (S1) 21.49 22.96 20.49 20.69 17.41
Support 2 (S2) 19.48 21.63 19.08 16.94
Support 3 (S3) 15.87 19.48 16.47
Support 4 (S4) 15.06